Zevra Therapeutics, Inc. · NASDAQ:ZVRA
Thompson Rahsaan sold 1,794 Zevra Therapeutics, Inc. shares (Form 4)
Traded May 11, 2026 · Filed May 13, 2026
On May 11, 2026, Thompson Rahsaan (Chief Legal & Compliance) sold 1,794 Zevra Therapeutics, Inc. shares at US$11.30 for US$20,272 under a trading plan, leaving 48,125 shares. Filed May 13, 2026 (Form 4).
- Sold
- 1,794 shares
- Price
- US$11.30
- Value
- US$20,272
- Holding after
- 48,125 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Legal & Compliance
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 11, 2026 | Common Stock | Sale | 1,794 | US$11.30 | 48,125 | Direct |
Source
Related
- Zevra Therapeutics, Inc.
- Thompson Rahsaan
- Zevra Therapeutics, Inc. shareholders
- Form 4 · Thompson Rahsaan · Aug 17, 2026
- Form 4 · Thompson Rahsaan · Jun 23, 2026
- Form 4 · McFarlane Neil F. · Oct 13, 2026
- Schedule 13G/A · Woodline Partners LP · Aug 14, 2026
- Form 4 · Watton Corey Michael · Aug 12, 2026
- Schedule 13G/A · FMR LLC · Aug 6, 2026
- Schedule 13G · Vanguard Capital Management LLC · Jul 31, 2026